Clinical Effect Of Intradiscal Application Of Allogeneic Mesenchymal Stem Cells Derived From Umbilical Cord Wharton’s Jelly (WJ-MSC) In Adults With Degenerative Disc Disease (DDD) Treated At BioXcellerator, Medellín, Colombia.

BioXcellerator Quality: BioXcellerator’s laboratory, has been designed to comply with both regulatory cGMP standards for quality and meet internationally recognized ISO standards that cover safety, air quality, and processing infusions that contain human cells. Disclaimer: Stem cell therapy offers no guarantees and is not promoted as a cure. This is similar to many other conventional medical treatments but it has scientific support. A review of the patient’s medical history is required to determine eligibility and approval for stem cell therapy. Any personal information provided is for internal and medical use with our medical providers only. BioXcellerator headquarters is located in Phoenix, Arizona. BioXcellerator Arizona is not a cell treatment facility or surgical center. Treatments are not conducted in our offices or in the U.S.  Since these advanced therapies are not yet approved by the FDA. Like all medical procedures, BioXcellerator procedures have a success and failure rate. Patient reviews and testimonials on this site should not be construed as a statement about the effectiveness of our treatments in general, they are individual perceptions that may or may not apply to everyone.

Clinical Effect Of Intradiscal Application Of Allogeneic Mesenchymal Stem Cells Derived From Umbilical Cord Wharton’s Jelly (WJ-MSC) In Adults With Degenerative Disc Disease (DDD) Treated At BioXcellerator, Medellín, Colombia.

Corporate Office

Colombia Treatment Center

1.888.567.2469

Treatment Options

Request Information